Destacado: Investigando la seguridad y tolerabilidad de la psilocibina de dosis única para el trastorno de estrés postraumático: Un ensayo clínico abierto no aleatorio (McGowan, et al, 2025) "COMP360 #psilocibina administrada en una sola sesión con apoyo psicológico se encontró que generalmente estaba bien tolerada y sin riesgos graves para la seguridad... #TEPT https://psychedelicmentalhealth.net/psilocybin-for-post-traumatic-stress-disorder #psicodelicos
Spotlight: Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial (McGowan, et al, 2025)
"In this trial, COMP360 psilocybin administered in a single session with psychological support was found to be generally well-tolerated and without serious risk to safety... treatment associated with rapid, sustained reduction in PTSD symptoms, improved functioning and quality of life to 12 weeks"